Literature DB >> 6337290

Immunomorphologic classification of spontaneous lymphoid cell neoplasms occurring in female BALB/c mice.

P K Pattengale, C H Frith.   

Abstract

WIth the use of a recently proposed, combined immunomorphologic classification (Pattengale-Taylor, 1981) for murine lymphomas and related leukemias, 70 spontaneously occurring lymphoid cell neoplasms from female BALB/cStCrl mice were evaluated and classified and then compared to the earlier Dunn classification (Dunn, 1954). The predominant lesion (i.e., 60% total incidence) in female BALB/c mice [previously called "reticulum cell sarcomas (neoplasm)", type B, by Dunn] was a lymphoid cell neoplasm derived from follicular center cells (i.e., follicular center cell [FCC] lymphoma). The B-cell nature was further confirmed in the majority (76%) of these FCC lymphomas by means of immunoperoxidase techniques that demonstrated the presence of cytoplasmic immunoglobulin (Clg). Smaller percentages of B-lymphoblastic (10% total incidence) and B-immunoblastic (7% total incidence) lymphomas were also observed. In addition, FCC, B-lymphoblastic, and B-immunoblastic lymphomas occurred in female BALB/c mice over 20 months of age. In contrast, Clg-negative lymphoblastic lymphomas involving the anterior mediastinum (and presumably T-cell in origin) occurred with a bimodal incidence in both young (13% total incidence at a mean age less than 6 mo) and old (10% total incidence at a mean age greater than 21 mo) female mice.

Entities:  

Mesh:

Year:  1983        PMID: 6337290

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  15 in total

1.  Experimental models of lymphoproliferative disease. The mouse as a model for human non-Hodgkin's lymphomas and related leukemias.

Authors:  P K Pattengale; C R Taylor
Journal:  Am J Pathol       Date:  1983-11       Impact factor: 4.307

2.  AKXD recombinant inbred strains: models for studying the molecular genetic basis of murine lymphomas.

Authors:  M L Mucenski; B A Taylor; N A Jenkins; N G Copeland
Journal:  Mol Cell Biol       Date:  1986-12       Impact factor: 4.272

3.  Lack of ecotropic virus involvement in induction of lymphomas in DBA/2J mice by 7,12-dimethylbenz(a)anthracene.

Authors:  J A Mercer; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Purification and Immune Phenotyping of B-1 Cells from Body Cavities of Mice.

Authors:  Vanessa Yenson; Nicole Baumgarth
Journal:  Methods Mol Biol       Date:  2021

Review 5.  Harnessing preclinical mouse models to inform human clinical cancer trials.

Authors:  David H Gutmann; Kim Hunter-Schaedle; Kevin M Shannon
Journal:  J Clin Invest       Date:  2006-04       Impact factor: 14.808

Review 6.  Mouse models for radiation-induced cancers.

Authors:  Leena Rivina; Michael J Davoren; Robert H Schiestl
Journal:  Mutagenesis       Date:  2016-05-21       Impact factor: 3.000

7.  Susceptibility of AKXD recombinant inbred mouse strains to lymphomas.

Authors:  D J Gilbert; P E Neumann; B A Taylor; N A Jenkins; N G Copeland
Journal:  J Virol       Date:  1993-04       Impact factor: 5.103

8.  Multiparameter analyses of spontaneous nonthymic lymphomas occurring in NFS/N mice congenic for ecotropic murine leukemia viruses.

Authors:  T N Fredrickson; H C Morse; R A Yetter; W P Rowe; J W Hartley; P K Pattengale
Journal:  Am J Pathol       Date:  1985-11       Impact factor: 4.307

9.  Promotional effects of azathioprine on peripheral B cell lymphomas in BALB/c mice induced by administration of 7,12-dimethylbenz[a]anthracene.

Authors:  K Fujiwara; T Yoshino; T Akagi; N Teramoto; K Hayashi
Journal:  J Cancer Res Clin Oncol       Date:  1994       Impact factor: 4.553

10.  Flow-cytometric identification and follow-up of mice exposed to x-irradiation: evaluation of a model system.

Authors:  A Johannisson; J Grawé; A Nilsson; B M Svedenstål; H Amnéus
Journal:  Radiat Environ Biophys       Date:  1995-08       Impact factor: 1.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.